These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10929279)

  • 21. Glutathione S-transferase A1, M1, P1 and T1 null or low-activity genotypes are associated with enhanced oxidative damage among haemodialysis patients.
    Suvakov S; Damjanovic T; Stefanovic A; Pekmezovic T; Savic-Radojevic A; Pljesa-Ercegovac M; Matic M; Djukic T; Coric V; Jakovljevic J; Ivanisevic J; Pljesa S; Jelic-Ivanovic Z; Mimic-Oka J; Dimkovic N; Simic T
    Nephrol Dial Transplant; 2013 Jan; 28(1):202-12. PubMed ID: 23034843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutathione S-transferase alpha 1 risk polymorphism and increased bilateral thalamus mean diffusivity in schizophrenia.
    Spalletta G; Piras F; Gravina P; Bello ML; Bernardini S; Caltagirone C
    Psychiatry Res; 2012; 203(2-3):180-3. PubMed ID: 22959778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers.
    He JQ; Ruan J; Connett JE; Anthonisen NR; Paré PD; Sandford AJ
    Am J Respir Crit Care Med; 2002 Aug; 166(3):323-8. PubMed ID: 12153964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial gadolinium-enhanced magnetic resonance imaging in patients with multiple sclerosis treated with mitoxantrone.
    Krapf H; Mauch E; Fetzer U; Laufen H; Kornhuber HH
    Neuroradiology; 1995 Feb; 37(2):113-9. PubMed ID: 7760994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uncovering and characterizing multiple sclerosis lesions: the aid of fluid-attenuated inversion recovery images in the presence of gadolinium contrast agent.
    Bagnato F
    J Neuroimaging; 2009 Jul; 19(3):201-4. PubMed ID: 19187471
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple sclerosis and exposure to organic solvents, investigated by genetic polymorphisms of the GSTM1 and CYP2D6 enzyme systems.
    Landtblom AM; Wastenson M; Ahmadi A; Söderkvist P
    Neurol Sci; 2003 Nov; 24(4):248-51. PubMed ID: 14658041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis.
    Radue EW; O'Connor P; Polman CH; Hohlfeld R; Calabresi P; Selmaj K; Mueller-Lenke N; Agoropoulou C; Holdbrook F; de Vera A; Zhang-Auberson L; Francis G; Burtin P; Kappos L;
    Arch Neurol; 2012 Oct; 69(10):1259-69. PubMed ID: 22751847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
    Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
    Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fat-saturated post gadolinium T1 imaging of the brain in multiple sclerosis.
    Al-Saeed O; Ismail M; Athyal R; Sheikh M
    Acta Radiol; 2011 Jun; 52(5):570-4. PubMed ID: 21498296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic effect of yoga in patients with hypertension with reference to GST gene polymorphism.
    Dhameja K; Singh S; Mustafa MD; Singh KP; Banerjee BD; Agarwal M; Ahmed RS
    J Altern Complement Med; 2013 Mar; 19(3):243-9. PubMed ID: 23062021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinal venous sheathing and the blood-retinal barrier in multiple sclerosis.
    Birch MK; Barbosa S; Blumhardt LD; O'Brien C; Harding SP
    Arch Ophthalmol; 1996 Jan; 114(1):34-9. PubMed ID: 8540848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automatic detection of gadolinium-enhancing multiple sclerosis lesions in brain MRI using conditional random fields.
    Karimaghaloo Z; Shah M; Francis SJ; Arnold DL; Collins DL; Arbel T
    IEEE Trans Med Imaging; 2012 Jun; 31(6):1181-94. PubMed ID: 22318484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.
    Bastianello S; Pozzilli C; Bernardi S; Bozzao L; Fantozzi LM; Buttinelli C; Fieschi C
    Neurology; 1990 Apr; 40(4):591-5. PubMed ID: 2320230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
    Jurcoane A; Wagner M; Schmidt C; Mayer C; Gracien RM; Hirschmann M; Deichmann R; Volz S; Ziemann U; Hattingen E
    J Magn Reson Imaging; 2013 Dec; 38(6):1454-61. PubMed ID: 23554005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis.
    Stickel F; Osterreicher CH; Datz C; Ferenci P; Wölfel M; Norgauer W; Kraus MR; Wrba F; Hellerbrand C; Schuppan D
    Arch Intern Med; 2005 Sep; 165(16):1835-40. PubMed ID: 16157826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutathione S-transferase K1 genotype and overweight status in schizophrenia patients: A pilot study.
    Oniki K; Kamihashi R; Tomita T; Ishioka M; Yoshimori Y; Osaki N; Tsuchimine S; Sugawara N; Kajiwara A; Morita K; Miyata K; Otake K; Nakagawa K; Ogata Y; Saruwatari J; Yasui-Furukori N
    Psychiatry Res; 2016 May; 239():190-5. PubMed ID: 27010189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoid receptor gene polymorphisms associated with more aggressive disease phenotype in MS.
    van Winsen LM; Hooper-van Veen T; van Rossum EF; Koper JW; Barkhof F; Polman CH; Uitdehaag BM
    J Neuroimmunol; 2007 May; 186(1-2):150-5. PubMed ID: 17395275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history.
    Harris JO; Frank JA; Patronas N; McFarlin DE; McFarland HF
    Ann Neurol; 1991 May; 29(5):548-55. PubMed ID: 1859184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions.
    Uysal E; Erturk SM; Yildirim H; Seleker F; Basak M
    AJR Am J Roentgenol; 2007 Mar; 188(3):697-702. PubMed ID: 17312056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.